A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- PMID: 35155455
- PMCID: PMC8835111
- DOI: 10.3389/fmed.2021.688159
A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Abstract
We propose a framework for the treatment, rehabilitation, and research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using a natural history of disease approach to outline the distinct disease stages, with an emphasis on cases following infection to provide insights into prevention. Moving away from the method of subtyping patients based on the various phenotypic presentations and instead reframing along the lines of disease progression could help with defining the distinct stages of disease, each of which would benefit from large prospective cohort studies to accurately describe the pathological mechanisms taking place therein. With a better understanding of these mechanisms, management and research can be tailored specifically for each disease stage. Pre-disease and early disease stages call for management strategies that may decrease the risk of long-term morbidity, by focusing on avoidance of further insults, adequate rest to enable recovery, and pacing of activities. Later disease stages require a more holistic and tailored management approach, with treatment-as this becomes available-targeting the alleviation of symptoms and multi-systemic dysfunction. More stringent and standardised use of case definitions in research is critical to improve generalisability of results and to create the strong evidence-based policies for management that are currently lacking in ME/CFS.
Keywords: ME/CFS; chronic fatigue syndrome; chronic illness; management; myalgic encephalomyelitis/chronic fatigue syndrome; post-viral fatigue syndrome; research.
Copyright © 2022 O'Boyle, Nacul, Nacul, Mudie, Kingdon, Cliff, Clark, Dockrell and Lacerda.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS.Front Neurol. 2020 Aug 11;11:826. doi: 10.3389/fneur.2020.00826. eCollection 2020. Front Neurol. 2020. PMID: 32849252 Free PMC article.
-
Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Rev Environ Health. 2015;30(4):223-49. doi: 10.1515/reveh-2015-0026. Rev Environ Health. 2015. PMID: 26613325 Review.
-
Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes.Disabil Rehabil. 2014;36(21):1790-7. doi: 10.3109/09638288.2013.874503. Epub 2013 Dec 27. Disabil Rehabil. 2014. PMID: 24369769
-
The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Medicina (Kaunas). 2023 Apr 6;59(4):719. doi: 10.3390/medicina59040719. Medicina (Kaunas). 2023. PMID: 37109676 Free PMC article.
-
Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Int J Mol Sci. 2023 Jul 26;24(15):11937. doi: 10.3390/ijms241511937. Int J Mol Sci. 2023. PMID: 37569313 Free PMC article. Review.
Cited by
-
The microbiome in post-acute infection syndrome (PAIS).Comput Struct Biotechnol J. 2023 Aug 5;21:3904-3911. doi: 10.1016/j.csbj.2023.08.002. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37602232 Free PMC article. Review.
-
Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression.Front Immunol. 2023 Dec 20;14:1294758. doi: 10.3389/fimmu.2023.1294758. eCollection 2023. Front Immunol. 2023. PMID: 38187396 Free PMC article.
-
Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics.J Clin Med. 2024 Feb 28;13(5):1369. doi: 10.3390/jcm13051369. J Clin Med. 2024. PMID: 38592199 Free PMC article.
-
What Primary Care Practitioners Need to Know about the New NICE Guideline for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults.Healthcare (Basel). 2022 Dec 2;10(12):2438. doi: 10.3390/healthcare10122438. Healthcare (Basel). 2022. PMID: 36553962 Free PMC article.
-
Return to work and health-related quality of life up to 1 year in patients hospitalized for COVID-19: the CO-FLOW study.BMC Med. 2023 Oct 2;21(1):380. doi: 10.1186/s12916-023-03083-3. BMC Med. 2023. PMID: 37784149 Free PMC article.
References
-
- Institute of Medicine (IOM) . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press; (2015). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous